Cipla Q4 Results, May 13 -- Pharmaceuticals company Cipla on Tuesday, May 13, reported a 30.12 per cent year-on-year (YoY) rise in its Q4FY25 consolidated net profit to Rs.1,221.84 crore compared to Rs.939.04 crore in the corresponding quarter of the previous financial year.

Revenue from sales rose 8.5 per cent YoY to Rs.6,597.72 crore from Rs.6,082.37 crore in Q4FY24. The pharmaceuticals segment clocked a revenue of Rs.6,503.63 crore in Q4FY25, up 8.5 per cent against Rs.5,996.38 crore in Q4FY24. Revenue from new ventures increased 35.44 per cent YoY to Rs.288.48 crore from Rs.212.99 crore in the same quarter of FY24.

Meanwhile, the company announced a final dividend of Rs.13 per equity share for FY25 and a special dividend of Rs.3 per...